• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Three questions for Masimo CEO Joe Kiani

Three questions for Masimo CEO Joe Kiani

November 4, 2011 By Brian Johnson

Joe Kiani is part of a pretty exclusive club. The founder, CEO and chairman of Masimo Corp. (NDSQ:MASI) built the company up from a start in his garage to a publicly traded company with more than 2,000 employees.

And while that accomplishment alone puts him in the same breath as business legends like Apple’s (NSDQ:AAPL) Steve Jobs or Microsoft’s (NSDQ:MSFT) Bill Gates, Kiani’s contribution to the world of medicine may be even more profound.

Whether it’s helping to revolutionize patient monitoring through Masimo’s breakthrough pulse oximetry technologies, or publicly taking on medical companies’ financial ties to group purchasing organizations, Kiani has worked to make health care safer for all patients.

Kiani, who will be our guest at the MassDevice Big 100 Regional Roundtable West Dec. 12, told us why he loves working in health care and how he got into med-tech in the first place. For the rest of his amazing story, join us in Irvine.

MassDevice: How did you get your start in the medical device space?

Joe Kiani: In the mid-1980s, as a young engineer at a local technology company, I became convinced that the use of adaptive signal processing could solve the problems of motion artifact and signal noise that plagued pulse oximetry – widely recognized as the 5th vital sign – and I set out to do just that.

I founded Masimo in 1989, working out of the garage of my condo in Southern California. I had a lofty goal: To help solve the “unsolvable” problems plaguing patient monitoring, like false pulse oximetry alarms due to motion and low perfusion. There was no shortage of challenges, naysayers, and almost insurmountable obstacles, but I, and we (at Masimo), persevered.

MassDevice: What do you enjoy most about the medical device space?

JK: I enjoy making an impact for patients, advancing health care and helping to improve the quality of patient care.

The best part of my job is when I hear that our engineering breakthroughs have saved lives and changed the outcomes of patients for the better. Whether it’s helping clinicians to dramatically reduce eye damage and blindness from retinopathy of prematurity in preemies, increasing the detection of congenital heart defects in newborns, preventing failure-to-rescue events and patient deaths due to unrecognized deterioration, or detecting life-threatening carbon monoxide poisoning, methemoglobinemia, respiratory distress, and internal bleeding before it becomes critical, Masimo’s innovations are saving lives and helping to transform the practice of medicine in ways most people thought were impossible.

Seeing these accomplishments come to life is the absolute best part of my job.

MassDevice: Why is this industry a good fit for you?

JK: As the son of an electrical engineer (my dad) and a nurse (my mom), my passion and inspiration for engineering and medical technology came naturally.

I grew up with a strong sense of curiosity, a passion for mathematics and a great ability to look beyond what others think is possible to bring impossible solutions to life. These qualities were cultivated in me, first by my parents and then reinforced by my education and training as an engineer, where I was drawn to solving the most complex engineering challenges and problems. I chose medical technology as a career because I wanted to make a contribution to society by helping people to live better lives and thrive in good health.

Filed Under: News Well Tagged With: Masimo, MassDevice Big 100 Regional Roundtable, MassDevice Q&A

More recent news

  • Steris inks $2.1B deal for operating room supplier Xodus Medical
  • Insulet’s Omnipod Discover data platform begins full US rollout
  • Siemens Healthineers exits general ultrasound to focus on cardiac imaging
  • Johnson & Johnson MedTech sets mid-2027 target for ortho spinoff, as Q3 device sales disappoint
  • Olympus receives FDA warning letter after international inspections

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy